P. Santabárbara
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.2%
- Molecular Biology top 5%
- Genetics top 1%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Gary M. ClarkLesley SeymourFrances A. ShepherdAndrea BezjakDongsheng TuMichael SmylieSumitra ThongprasertMircea Dediu
- Topics
- Lung Cancer Research Studies (11 papers)Lung Cancer Treatments and Mutations (11 papers)Lymphoma Diagnosis and Treatment (6 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
P. Santabárbara
33 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 4.5k
- Pulmonary and Respiratory Medicine 4.5k
- Molecular Biology 1.5k
- Genetics 930
- Pathology and Forensic Medicine 912
Countries citing papers authored by P. Santabárbara
This map shows the geographic impact of P. Santabárbara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Santabárbara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Santabárbara more than expected).
Fields of papers citing papers by P. Santabárbara
This network shows the impact of papers produced by P. Santabárbara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Santabárbara. The network helps show where P. Santabárbara may publish in the future.
Co-authorship network of co-authors of P. Santabárbara
This figure shows the co-authorship network connecting the top 25 collaborators of P. Santabárbara. A scholar is included among the top collaborators of P. Santabárbara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Santabárbara. P. Santabárbara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 47 | |
| 3 | 4 | |
| 4 | 12 | |
| 5 | 7 | |
| 6 | 27 | |
| 7 | 3 | |
| 8 | 140 | |
| 9 | Erlotinib in Previously Treated Non–Small-Cell Lung Cancerbreakdown → | 4281 |
| 10 | 2 | |
| 11 | 16 | |
| 12 | Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug. | 28 |
| 13 | A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies. | 2 |
| 14 | 84 | |
| 15 | 2 | |
| 16 | 9 | |
| 17 | 53 | |
| 18 | 61 | |
| 19 | 6 | |
| 20 | 1 |
About P. Santabárbara
P. Santabárbara is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 33 papers that have together received 6.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (4.5k citations), Pulmonary and Respiratory Medicine (4.5k citations) and Genetics (930 citations). P. Santabárbara has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Gary M. Clark, Lesley Seymour, Frances A. Shepherd, Andrea Bezjak, Dongsheng Tu, Michael Smylie, Sumitra Thongprasert, Mircea Dediu, D. Johnston and Daniel de Castro. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.